Share Fund
The primary objective of the scheme is to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies across market capitalization spectrum. However, there can be no assurance or guarantee that the investment objective of the scheme would be achieved.
Suitability
This product is suitable for investors who are seeking
• Long term capital growth
• Investment in equity instruments by capitalizing on opportunities arising in the market dynamicallyModerately High Leve
| Scheme Class | Equity |
| Scheme Category | Value |
| Expense Ratio | 1.47% |
| Min subscription | ₹ 5,000 |
| Scheme Type | Open-ended |
| Scheme AUM (in Crs.) | ₹ 4,406 |
| AMC AUM (in Crs.) | ₹ 1,59,694 |
| Min Addition Subscription | ₹ 1,000 |
| Benchmark Type | S&P BSE 500 India TR INR |
| Exit Load | Exit load of 1.0%, if redeemed between (0-1) years. No Exit load, if redeemed after 1 years. |
| Fund | Min SIP Inv. | Min Inv. | Returns 3Y |
|---|---|---|---|
Aditya Birla Sun Life Pure Value Fund - Direct Plan | 1000 | 1000 | -6.81% |
L&T India Value Fund - Direct Plan | 1000 | 1000 | 2.51% |
L&T India Value Fund - Direct Plan | 1000 | 1000 | 2.51% |
| Company | Holding Type | Asset(%) |
|---|---|---|
Infosys Ltd | Equity | 9 |
HDFC Bank Ltd | Equity | 8 |
ICICI Bank Ltd | Equity | 7 |
Axis Bank Ltd | Equity | 5 |
Bharti Airtel Ltd | Equity | 4 |
ITC Ltd | Equity | 3 |
Escorts Ltd | Equity | 3 |
Eicher Motors Ltd | Equity | 2 |
Jubilant Foodworks Ltd | Equity | 2 |
Sun Pharmaceuticals Industries Ltd | Equity | 2 |
| Asset | Percent |
|---|---|
Equity | 98 |
Cash | 2 |
Equity - Warrants Rights (Call) | 0 |
| Sector | Percent |
|---|---|
Financial Services | 27 |
Consumer Cyclical | 14 |
Technology | 12 |
Healthcare | 11 |
Industrials | 8 |
Fund Manager
Amit Premchandani
2+ years of experience
Vetri Subramaniam
3+ years of experience
About
service@uti.co.in
Phone
1800 26 61230
Address
UTI Tower , `GN' Block,,Bandra Kurla Complex,,Bandra (E), Mumbai - 400 051
